Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiming Granule for diabetic microangiopathy with eye and kidney involvement
ChiCTR2000034190Phase 4Recruiting
- Sponsor
- Gansu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 4 trial of qiming granule in diabetic microangiopathy, diabetic retinopathy (DR) and diabetic glomerulosclerosis (2 arms), sponsored by Gansu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Cystatin-C, Homocysteine and 5 more. Started Jun 2020; status: recruiting.
02
Drugs
qiming granule
03
Conditions
diabetic microangiopathydiabetic retinopathy (DR)diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2000034190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034190.